Stay updated on VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.

Latest updates to the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note clarifying that PubMed publications are automatically filled from PubMed and may not all relate to the study. Updated page revision to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer displays the government funding lapse notice, which is an administrative update and does not affect the trial details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedThe new screenshot shows minor UI/layout tweaks and small copy edits; core study information such as eligibility criteria, interventions, outcomes, and listed locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedUpdated operating-status notice and v3.2.0 release; removed two carcinoma terms and old v3.1.0 tag.SummaryDifference3%

- Check78 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The Back to Top link was removed.SummaryDifference0.2%

Stay in the know with updates to VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.